← Leaderboards
Stanley A Schwartz
Va Western New York Healthcare System
$2,204,583
Attributed
$2,204,583
Total exposure
8
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $390K · FY2005–25$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,204,583 · 7
VA$0 · 1
By mechanism
R01$1,526,699 · 2
R21$368,870 · 1
M01$309,014 · 4
I01$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectMedical ComplicationClinical ResearchResponseDiabetes Mellitus TherapyDiabetic NeuropathyApoptosisEpidemiologyDiabetic NephropathyLongitudinal Human StudyInnovationPeripheral Blood Vessel DisorderEngineeringHuman Therapy EvaluationPathologic ProcessDiabetic RetinopathyDisease /Disorder Prevention /ControlAtherosclerosisClinical DataInsulinInsulin Dependent Diabetes MellitusCerebral ArteryOutcomes ResearchIl8 Gene
Grant awards (21)
A Multimodal Hierarchical Theranostic Nanoparticle for Castration Resistant Prostate Cancer$0
I01 · FY2025 · VA · contact PI
A Multimodal Hierarchical Theranostic Nanoparticle for Castration Resistant Prostate Cancer$0
I01 · FY2024 · VA · contact PI
A Multimodal Hierarchical Theranostic Nanoparticle for Castration Resistant Prostate Cancer$0
I01 · FY2023 · VA · contact PI
A Multimodal Hierarchical Theranostic Nanoparticle for Castration Resistant Prostate Cancer$0
I01 · FY2022 · VA · contact PI
IL-8 targeted Nanotherapy for Prostate Cancer.$162,027
R21 · FY2013 · CA · contact PI
IL-8 targeted Nanotherapy for Prostate Cancer.$206,843
R21 · FY2012 · CA · contact PI
Integration of Clinical, Genomic and Proteomic Data using a Bioinformatic Approac$389,985
R01 · FY2010 · AI · contact PI
Integration of Clinical, Genomic and Proteomic Data using a Bioinformatic Approac$389,985
R01 · FY2009 · AI · contact PI
EPIDEMIOLOGY OF DIABETES INTERVENTION AND COMPLICATIONS$13,294
M01 · FY2005 · RR
EDIC/GENETICS STUDY$1,363
M01 · FY2005 · RR
Epidemiology of Diabetes Intervention and Complications$17,400
M01 · FY2004 · RR
EDIC/Genetics Study$3,551
M01 · FY2004 · RR
MOLECULAR MECHANISMS OF OPIOIDS AS COFACTORS IN AIDS$256,304
R01 · FY2002 · DA
EPIDEMIOLOGY OF DIABETES INTERVENTION AND COMPLICATIONS$124,146
M01 · FY2002 · RR
MOLECULAR MECHANISMS OF OPIOIDS AS COFACTORS IN AIDS$248,836
R01 · FY2001 · DA
EPIDEMIOLOGY OF DIABETES INTERVENTION AND COMPLICATIONS$124,146
M01 · FY2001 · RR
EPIDEMIOLOGY OF DIABETES INTERVENTION AND COMPLICATIONS$0
M01 · FY2001 · RR
MOLECULAR MECHANISMS OF OPIOIDS AS COFACTORS IN AIDS$241,589
R01 · FY2000 · DA
EPIDEMIOLOGY OF DIABETES INTERVENTION AND COMPLICATIONS$25,114
M01 · FY2000 · RR
EPIDEMIOLOGY OF DIABETES INTERVENTION AND COMPLICATIONS$0
M01 · FY2000 · RR
EPIDEMIOLOGY OF DIABETES INTERVENTION AND COMPLICATIONS$0
M01 · FY2000 · RR